NNIT Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 1/6
NNIT's earnings have been declining at an average annual rate of -48.8%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 18.8% per year. NNIT's return on equity is 8.3%, and it has net margins of 4%.
Key information
-48.8%
Earnings growth rate
-49.2%
EPS growth rate
| Healthcare Services Industry Growth | 12.5% |
| Revenue growth rate | -18.8% |
| Return on equity | 8.3% |
| Net Margin | 4.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How NNIT makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,828 | 73 | 329 | 0 |
| 31 Mar 24 | 1,778 | 40 | 329 | 0 |
| 31 Dec 23 | 1,728 | 6 | 329 | 0 |
| 30 Sep 23 | 1,321 | -133 | 381 | 0 |
| 30 Jun 23 | 1,613 | -175 | 381 | 0 |
| 31 Mar 23 | 1,218 | -241 | 457 | 0 |
| 31 Dec 22 | 1,500 | -258 | 415 | 0 |
| 30 Sep 22 | 692 | -304 | 226 | 0 |
| 30 Jun 22 | 652 | -292 | 225 | 0 |
| 31 Mar 22 | 2,847 | -71 | 203 | 0 |
| 31 Dec 21 | 1,369 | -175 | 142 | 0 |
| 30 Sep 21 | 2,888 | 9 | 266 | 0 |
| 30 Jun 21 | 2,848 | 28 | 252 | 0 |
| 31 Mar 21 | 2,839 | 72 | 218 | 0 |
| 31 Dec 20 | 2,830 | 76 | 222 | 0 |
| 30 Sep 20 | 2,882 | 116 | 229 | 0 |
| 30 Jun 20 | 2,987 | 157 | 232 | 0 |
| 31 Mar 20 | 3,030 | 177 | 233 | 0 |
| 31 Dec 19 | 3,058 | 183 | 236 | 0 |
| 30 Sep 19 | 3,080 | 210 | 232 | 0 |
| 30 Jun 19 | 3,050 | 209 | 230 | 0 |
| 31 Mar 19 | 3,058 | 231 | 234 | 0 |
| 31 Dec 18 | 3,007 | 236 | 234 | 0 |
| 30 Sep 18 | 2,964 | 224 | 243 | 0 |
| 30 Jun 18 | 2,892 | 199 | 250 | 0 |
| 31 Mar 18 | 2,835 | 189 | 251 | 0 |
| 31 Dec 17 | 2,851 | 199 | 253 | 0 |
| 30 Sep 17 | 2,841 | 198 | 244 | 0 |
| 30 Jun 17 | 2,854 | 226 | 242 | 0 |
| 31 Mar 17 | 2,817 | 220 | 243 | 0 |
| 31 Dec 16 | 2,765 | 216 | 243 | 0 |
| 30 Sep 16 | 2,719 | 212 | 265 | 0 |
| 30 Jun 16 | 2,677 | 211 | 269 | 0 |
| 31 Mar 16 | 2,648 | 206 | 268 | 0 |
| 31 Dec 15 | 2,600 | 212 | 264 | 0 |
| 30 Sep 15 | 2,566 | 216 | 250 | 0 |
| 30 Jun 15 | 2,520 | 218 | 241 | 0 |
| 31 Mar 15 | 2,474 | 223 | 230 | 0 |
| 31 Dec 14 | 2,410 | 209 | 224 | 0 |
| 30 Sep 14 | 2,334 | 206 | 223 | 0 |
| 30 Jun 14 | 2,289 | 197 | 214 | 0 |
| 31 Mar 14 | 2,257 | 199 | 215 | 0 |
| 31 Dec 13 | 2,205 | 186 | 211 | 0 |
Quality Earnings: 0R5Z has a high level of non-cash earnings.
Growing Profit Margin: 0R5Z became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0R5Z's earnings have declined by 48.8% per year over the past 5 years.
Accelerating Growth: 0R5Z has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 0R5Z has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: 0R5Z's Return on Equity (8.3%) is considered low.